New Product - Nasodine Sinus Rinse
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Firebrick Pharma Limited has announced the launch of its new product, Nasodine® Sinus Rinse, which is now available for healthcare professionals in Singapore. This product is an antiseptic nasal and sinus wash kit that utilizes povidone-iodine for its germ-killing properties. The announcement highlights the product's intended uses, including treatment for sinusitis and pre- and post-operative antisepsis.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Firebrick Pharma Limited on 6ix
Earlier from Firebrick Pharma
- Change in substantial holding - Pharma Nutria
- Cleansing Notice
- Application for quotation of securities - FRE
- Nasodine Nasal Spray Approved in the Philippines
- Notice of AGM & Proxy Form & Letter to Shareholders
Later from Firebrick Pharma
- September 2026 Quarterly Activity Report & Appendix 4C
- Results of Annual General Meeting
- Proposed issue of securities - FRE
- Change of Director's Interest Notice - Al Moghaddam
- Change of Director's Interest Notice - Peter Molloy
Follow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma